The relationship of comorbidities to mortality and cause of death in patients with differentiated thyroid carcinoma.

ABSTRACT: Understanding how comorbidities contribute to death in cancer patients is becoming an important topic. The present study assessed the role of comorbidities in overall mortality and causes of death in patients with differentiated thyroid carcinoma (DTC). This retrospective cohort study included 2070 patients who underwent thyroidectomy for DTC at a single institution between 2002 and 2005. Probabilities of overall, DTC-specific and other-cause death were examined according to the number of comorbidities, with consideration for competing events. The estimated 15-year cumulative incidences of overall, DTC-specific, and other-cause death were 7.3%, 1.6%, and 5.7%, respectively. Taking the group without comorbidities as a reference, we found that the group with 1-2 comorbidities and the group w

SUBMITTER: Lee YK 

PROVIDER: S-EPMC6685995 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature